Perceived barriers of DCTs can be quickly overcome to ensure their viability in clinical research.
In this interview from DIA 2023, Janice Chang, CEO of TransCelerate BioPharma, discusses the unique opportuntities presented by decentralized clinical trials (DCTs).
Clinical Trials in Indonesia: Challenges and Opportunities for Industry Sponsors
June 17th 2024Improved diversity in clinical trials can be achieved by exploring opportunities for research in developing countries that have not historically participated in large-scale, industry-sponsored clinical trials.